ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2005
New restrictions on celecoxib (Celebrex) use and the withdrawal of valdecoxib (Bextra).
Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 40 citations in OpenAlex.
- Cyclooxygenase-2 selective inhibitors in cancer prevention and therapy: inflammopharmacological basis and translational prospects.Medical oncology (Northwood, London, England) · 2026Review
- Recent advances in nanocrystals for arthritis drug delivery.Expert opinion on drug delivery · 2025Review
- ER-associated degradation ligase HRD1 links ER stress to DNA damage repair by modulating the activity of DNA-PKcs.Proceedings of the National Academy of Sciences of the United States of America · 2024Article
- Why Pharmacovigilance of Non-steroidal Anti-inflammatory Drugs is Important in India?Endocrine, metabolic & immune disorders drug targets · 2024Review
- The Safety of Celecoxib as an Acute Treatment for Migraine: A Narrative Review.Pain and therapy · 2023Review
- The need for "gentle medicine" in a post Covid-19 world.Medicine, health care, and philosophy · 2021Review
- Pharmacology-informed prediction of the risk posed to fish by mixtures of non-steroidal anti-inflammatory drugs (NSAIDs) in the environment.Environment international · 2021Article
- Pharmacovigilance in perspective: drug withdrawals, data mining and policy implications.F1000Research · 2019Review
- Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale.PloS one · 2009Article
- Coxibs and cardiovascular risk.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2005Article
- Coxibs and cardiovascular risk.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2005Article
- Coxibs and cardiovascular risk.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2005Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
2 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.